Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

Boosting Klotho protein levels in mice improves physical and cognitive aging, offering potential for future longevity ...

Klotho Neurosciences, Inc. (KLTO), a U.S.-based biogenetics company, today announced that over the course of the last ten days, it ...

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...

Klotho didn’t just protect their brains, the researchers concluded — it enhanced them. Experiments on more mice turned up similar results. “I just couldn’t believe it — was it true, ...

Klotho Neurosciences (KLTO) witnessed an astonishing 800% increase in stock value on June 9, 2025, after revealing positive results from pre-clinical studies. The company’s investigations ...

Klotho, the study showed, improved the cognitive performance and even the mobility of mice whose brains were riddled with clumps and tangles of toxic proteins that are hallmarks of dementia and ...

Klotho, the ancient Greek goddess of fate, is responsible for spinning the thread of life. In the human body, a protein with the same name might also be able to bring some life back to an aging brain.